“Enacting comprehensive drug-pricing reforms during a presidential election year is already an unlikely prospect…” said Marc Samuels, CEO of healthcare consulting firm ADVI.Read more
“As a care delivery model, the OCM is awesome. But Medicare did not go into this to improve the quality of cancer care. They went into this to save money.”Read more
“A lot of these plans are moving people into payment structures which put downward pressure on reimbursement. That’s something that economists have shown will have a negative impact on innovation,” Davison said.
“If you are lowering reimbursement, you are going to have a negative impact on physician pipeline issues, and that will have a negative impact on access,” she said.Read more
“What everyone can agree on is that a hospital’s patients understand what they’re going to be responsible for paying,” said Rebecca Davison, a director at consulting firm ADVI Health.Read more